Mosquito-Borne Infections Testing Market to Hit $2.1 Billion by 2036

Market expected to grow at 4.2% CAGR driven by climate change and need for outbreak preparedness

Published on Feb. 26, 2026

Got story updates? Submit your updates here. ›

The global Mosquito-Borne Infections Testing Market is projected to reach a valuation of USD 1.4 billion in 2026 and expand to USD 2.1 billion by 2036, growing at a steady compound annual growth rate (CAGR) of 4.2%. This growth is driven by an urgent need for outbreak preparedness and expanded laboratory capacity as health systems worldwide prioritize rapid detection to mitigate the rising threat of arboviruses.

Why it matters

The expansion of the Mosquito-Borne Infections Testing Market is primarily fueled by climate change, which is extending vector habitats into previously non-endemic geographic regions. Additionally, the surge in global travel and trade has increased the demand for testing imported cases. Public health elimination programs are also playing a critical role, requiring widespread surveillance testing to monitor and control the spread of malaria, dengue, and Zika.

The details

The grilling & frying segment stands as the market leader with a 45.1% share, driven by the versatility of testing platforms that can accommodate various high-demand diagnostic assays in both clinical and field settings. Disposable materials account for 58.1% of the market, reflecting the need for hygiene and simplified cleanup in laboratory environments. The residential segment holds a 51.9% share, reflecting the increasing shift toward home-based testing and point-of-care accessibility in disease detection strategies.

  • The Mosquito-Borne Infections Testing Market is set on a consistent upward trajectory through the next decade, starting at USD 1.4 billion in 2026 and reaching USD 2.1 billion by 2036.

The players

F. Hoffmann-La Roche Ltd

A leading global pharmaceutical and diagnostics company.

Abbott Laboratories

A multinational medical devices and health care company.

Danaher Corporation

A diversified science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services.

Thermo Fisher Scientific Inc.

A multinational biotechnology product development company that provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics.

Bio-Rad Laboratories, Inc.

A multinational life science research and clinical diagnostic products company.

Got photos? Submit your photos here. ›

The takeaway

The Mosquito-Borne Infections Testing Market is set to experience significant growth over the next decade, driven by the urgent need for outbreak preparedness and expanded laboratory capacity to mitigate the rising threat of arboviruses. The market's expansion is fueled by climate change, increased global travel and trade, and public health elimination programs, highlighting the critical role of rapid detection and surveillance in controlling the spread of diseases like malaria, dengue, and Zika.